These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels. Rossini A, Gazzola GB, Ravaggi A, Agostinelli E, Biasi L, Albertini A, Radaeli E, Cariani E. Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954 [Abstract] [Full Text] [Related]
9. Transmission of HCV infection by RIBA indeterminate and positive blood units. Kolho E, Naukkarinen R, Krusius T. Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012 [Abstract] [Full Text] [Related]
13. A high risk of hepatitis C infection among Egyptian blood donors: the role of parenteral drug abuse. Bassily S, Hyams KC, Fouad RA, Samaan MD, Hibbs RG. Am J Trop Med Hyg; 1995 Jun; 52(6):503-5. PubMed ID: 7541968 [Abstract] [Full Text] [Related]
15. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro. Edelenyi-Pinto M, Carvalho AP, Nogueira C, Ferreira Júnior O, Schechter M. Mem Inst Oswaldo Cruz; 1993 Jun; 88(2):305-7. PubMed ID: 7509022 [Abstract] [Full Text] [Related]
20. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. Barrera JM, Bruguera M, Ercilla MG, Sánchez-Tapias JM, Gil MP, Costa J, Gelabert A, Rodés J, Castillo R. Ann Intern Med; 1991 Oct 15; 115(8):596-600. PubMed ID: 1909848 [Abstract] [Full Text] [Related] Page: [Next] [New Search]